Together we Drive the Future

Antibodies in Oncology & Beyond

EARLY BIRD DISCOUNT! Register by May 11, 2017 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!

registration button

Antibody & Protein Therapeutics Summit

Antibodies in Oncology & Beyond

Antibody Drug Conjugates

Novel Protein Therapeutics

Subscribe for updates

Dear Colleague,

We invite you to attend the Antibodies in Oncology & Beyond Conference, which will take place July 11-12, 2017 in Baltimore MD. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.

Session Topics:

  1. Novel Protein Discovery Technologies
  2. Immunotherapeutic Approaches in Oncology
  3. Strategies for Antibodies Against Infectious Diseases
  4. Advances in Antibody Engineering
  5. Regulatory Considerations to Bring Antibody Therapies to Market

We hope to see you there!


Best regards,

The 2017 Advisory Committee


2017 Program Director
Victor-Jeffrey Leyton, Université de Sherbrooke
2017 Advisory Board Members
Neeraj Agrawal, Amgen
Ahuva Nissim, Queen Mary University
Amandeep Gakhal, Sutro Biopharma
Ann White, University of Southampton
Bill Harriman , Crystal Bioscience
Birgit Schoeberl, Merrimack Pharmaceuticals
Elad Firnberg, Revolve Biotechnologies
Ernesto Freire, Johns Hopkins University
Nicolas Fischer, Novimmune SA
Gregory Adams, Eleven Biotherapeutics
Janos Luka, Walter Reed Army Institute of Research
Matthew Robinson, Immunome, Inc
Michael R. Dyson, IONTAS Ltd
Andreas Pahl, Heidelberg Pharma
Pedro Berraondo López, CIMA, University of Navarra
Darren Schofield, MedImmune
Seema Kumar, EMD Serono
Jamshid Tanha, University of Ottawa
Thomas Pillow, Genentech
Medha J. Tomlinson, Abbvie
Yan Chen, Genentech